The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Will Be The Estimated Market Valuation Of The Psoriatic Arthritis Treatment Market By The End Of 2030?
The psoriatic arthritis treatment market size has seen significant expansion in recent years. It is anticipated to grow from $13.17 billion in 2025 to $14.36 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.0%. Historically, this growth can be ascribed to factors including the limited availability of advanced therapies, reliance on conventional NSAIDs and DMARDs, the increasing prevalence of psoriatic arthritis, growing patient awareness, and the expansion of hospital and retail pharmacy infrastructure.
The psoriatic arthritis treatment market size is projected to experience substantial growth in the upcoming years. It is forecast to expand to $20.62 billion by 2030, achieving a compound annual growth rate (CAGR) of 9.5%. This growth throughout the forecast period stems from the advancement of interleukin inhibitors and jak inhibitors, the increasing acceptance of biologics, the proliferation of personalized medicine strategies, a surge in telemedicine adoption for managing chronic diseases, and increased government and insurance backing for psoriatic arthritis care. Prominent trends expected during the forecast period involve the rising uptake of biologics and targeted synthetic dmards, enhanced awareness surrounding the early diagnosis and management of psoriatic arthritis, the development of personalized treatment options for joint and skin symptoms, the broadening of hospital and specialty pharmacy distribution channels, and the integration of telemedicine and remote monitoring services for psoriatic arthritis patients.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3458&type=smp
What Drivers Are Shaping The Future Growth Of The Psoriatic Arthritis Treatment Market?
The augmented healthcare spending is projected to stimulate the expansion of the psoriatic arthritis treatment market moving forward. Healthcare spending, also referred to as healthcare expenditure, signifies the financial resources allocated to support the provision of healthcare services, products, and programs within a specific country, region, or healthcare system. This expenditure aids the diagnostic process by funding medical appointments, laboratory tests, and imaging studies. Patients with PsA often undergo comprehensive evaluations to confirm the diagnosis, determine the extent of joint involvement, and assess any associated comorbidities. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, in 2023, U.S. health care expenditures increased by 7.5%, climbing to $4.9 trillion, or roughly $14,570 for each individual. Consequently, the uptick in healthcare spending is propelling the growth of the psoriatic arthritis treatment market.
Which Segment Classifications Shape The Psoriatic Arthritis Treatment Market?
The psoriatic arthritis treatment market covered in this report is segmented –
1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDS), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biologics, Other Drug Classes
2) By Route Of Administration: Oral, Parenteral, Topical
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Traditional NSAIDs, COX-2 Inhibitors
2) By Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Conventional DMARDs, Targeted Synthetic DMARDs
3) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Other Biologics
4) By Other Drug Classes: Corticosteroids, Topical Treatments, Janus Kinase (JAK) Inhibitors
How Are Trends Impacting The Psoriatic Arthritis Treatment Market?
Leading companies in the psoriatic arthritis treatment market are securing approvals for new drugs like Cosentyx to enhance their profitability. Cosentyx is a medication utilized for managing autoimmune conditions such as non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and enthesitis-related arthritis. For instance, in October 2023, Novartis, a Switzerland-based pharmaceutical firm, announced that its novel drug Cosentyx had received approval from the Food and Drug Administration. Cosentyx functions as a human interleukin-17A antagonist, working by preventing the activation of the IL-17A protein, which helps minimize potential patient side effects including edema, discomfort, and skin rashes. Cosentyx has demonstrated effectiveness in addressing psoriatic arthritis symptoms, with its action commencing in as little as three weeks. It offers relief from several psoriatic arthritis symptoms, such as joint pain and tenderness, back discomfort, and skin problems.
Which Companies Are Expanding Their Footprint In The Psoriatic Arthritis Treatment Market?
Major companies operating in the psoriatic arthritis treatment market are AbbVie Inc., Amgen Astellas BioPharma K.K., Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer Inc., Merck & Co. Inc., AstraZeneca plc, Sanofi SA, Otsuka Pharmaceutical Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Bayer AG, Eisai Inc., Janssen Pharmaceuticals Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Chugai Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd.
Read the full psoriatic arthritis treatment market report here:
Which Geographic Regions Are Influencing Demand In The Psoriatic Arthritis Treatment Market?
North America was the largest region in the psoriatic arthritis treatment market in 2025. The regions covered in the psoriatic arthritis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Psoriatic Arthritis Treatment Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3458&type=smp
Browse Through More Reports Similar to the Global Psoriatic Arthritis Treatment Market 2026, By The Business Research Company
Musculoskeletal Disorder Drugs Market Report 2026
Microbiome Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/microbiome-therapeutics-global-market-report
Orthobiologics Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model